- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | NeuroOne: Product Revenue Jumps 105% As Gross Margin Expands Nearly 20 Percentage Points In Fiscal Q3 2025 | 1 | pulse2.com | ||
| 13.08. | NeuroOne expects FY2026 product orders of about $11.2M while working to clear backlog by Q4 2026 | 2 | Seeking Alpha | ||
| 13.08. | Earnings Call: NeuroOne Medical steigert Umsatz im dritten Quartal, Aktie gibt dennoch nach | 1 | Investing.com Deutsch | ||
| 13.08. | NeuroOne Medical Technologies GAAP EPS of -$0.28 misses by $0.06, revenue of $2M misses by $0.55M | 1 | Seeking Alpha | ||
| NEUROONE MEDICAL TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 13.08. | NEUROONE MEDICAL TECHNOLOGIES Corp - 10-Q, Quarterly Report | - | SEC Filings | ||
| 13.08. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | - | SEC Filings | ||
| 13.08. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9% | 1.233 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins... ► Artikel lesen | |
| 11.08. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Achieves Major Milestone With ISO 13485 Certification | 1.449 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Achieves Major Milestone With ISO 13485 Certification 11.08.2026 / 14:35 CET/CEST
The issuer is... ► Artikel lesen | |
| 03.08. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time | 302 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m.... ► Artikel lesen | |
| 30.07. | EQS-News: NeuroOne Medical Technologies: NeuroOne Releases CNS Drug Delivery White Paper Ahead of Planned Fiscal Year-End Availability of the StereoCED Platform | 446 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Science
NeuroOne Releases CNS Drug Delivery White Paper Ahead of Planned Fiscal Year-End Availability of the StereoCED Platform... ► Artikel lesen | |
| 28.07. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Highlights Potential Paradigm Shift for Patients Treated With the OneRF(R) Brain Ablation System Based on Reports by Physicians | 386 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Highlights Potential Paradigm Shift for Patients Treated With the OneRF(R) Brain Ablation System Based... ► Artikel lesen | |
| 16.07. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial | 432 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial 16.07.2026... ► Artikel lesen | |
| 29.06. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Added to Russell Microcap(R) Index | 377 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Added to Russell Microcap(R) Index 29.06.2026 / 14:35 CET/CEST
The issuer is solely responsible... ► Artikel lesen | |
| 25.06. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 424 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 25.06.2026 / 23:03 CET/CEST
The issuer... ► Artikel lesen | |
| 16.06. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index | 416 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Science
NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index 16.06.2026 / 14:35 CET/CEST
The issuer... ► Artikel lesen | |
| 12.06. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | 2 | SEC Filings | ||
| 12.06. | NEUROONE MEDICAL TECHNOLOGIES Corp - 10-Q/A, Quarterly Report | 2 | SEC Filings | ||
| 08.06. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m. Pacific Time | 362 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12:00 p.m.... ► Artikel lesen | |
| 28.05. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026 | 419 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting... ► Artikel lesen | |
| 22.05. | EQS-News: NeuroOne Medical Technologies: NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026 | 566 | EQS Group (EN) | EQS-News: NeuroOne Medical Technologies
/ Key word(s): Financial
NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026... ► Artikel lesen |
1 2 3 Weiter >>
44 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CERENOME | 2,540 | +0,40 % | Cerenome, Inc.: Cerenome Reports Second Quarter 2026 Financial Results and Business Update | HOUSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), a CNS oncology company advancing an integrated platform that combines precision diagnostics... ► Artikel lesen | |
| ORGANON | 11,785 | +0,13 % | Dividendenbekanntmachungen (14.08.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADM HAMBURG AG DE0007269003 - 13,58 EUR AGCO CORPORATION US0010841023 0,3 USD 0,2602 EUR AGNT INC US30212W1009 0,05 USD 0,0433... ► Artikel lesen | |
| QUIDELORTHO | 12,285 | -4,66 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| NANO-X IMAGING | 0,863 | -1,44 % | Nano-X Imaging Ltd: Nanox to Report Second Quarter 2026 Financial Results on September 9, 2026 | ||
| ROCKWELL MEDICAL | 8,140 | +2,84 % | XFRA RWM: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILROCKWELL MEDICAL... ► Artikel lesen | |
| NUWELLIS, INC | 1,000 | -0,99 % | Nuwellis, Inc. - 8-K, Current Report | ||
| PROCEPT BIOROBOTICS | 21,080 | +0,05 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| NEURONETICS | 2,490 | -2,73 % | Neuronetics Reports Second Quarter 2026 Financial and Operating Results | MALVERN, Pa., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the "Company" or "Neuronetics"), a leader in interventional mental health that combines its NeuroStar® TMS technology... ► Artikel lesen | |
| OPTIMIZERX | 7,750 | 0,00 % | OptimizeRx Corp - S-8, Securities to be offered to employees in employee benefit plans | ||
| OWLET | 5,180 | 0,00 % | Owlet: Hauptversammlung stimmt für Vergütungsplan und wählt Direktoren | ||
| PAVMED | 4,355 | +6,87 % | PAVmed Inc.: PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results | Veris Health accelerated its commercial engagement with OSU-The James
Veris Health implantable physiological monitor achieved development milestones towards upcoming... ► Artikel lesen | |
| ORTHOFIX MEDICAL | 8,000 | -1,84 % | Orthofix Medical Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| NEXGEL | 0,350 | -1,77 % | NEXGEL appoints Brian Kieser as interim CEO after Adam Levy steps down | ||
| PICARD MEDICAL | 9,585 | 0,00 % | Why Is Picard Medical Stock Gaining Monday? | ||
| QTREX QUANTUM | 0,820 | +0,18 % | QTREX Quantum nimmt 10 Millionen US-Dollar über Direktplatzierung ein |
Das Unternehmen NEUROONE MEDICAL TECHNOLOGIES CORPORATION kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -0,49 % bei einem Aktienkurs von 2,020 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEUROONE MEDICAL TECHNOLOGIES CORPORATION finden Sie auf Wallstreet Online.